On Thursday night, the United States Senate passed S. Res. 347, a resolution sponsored by U.S. Senator Jerry Moran (R-KS), recognizing our nation's commitment to cancer research and commemorating the 40th anniversary of the signing of the National Cancer Act. Sen. Moran is the lead Republican sponsor of the bipartisan resolution, which has 45 Senate co-sponsors and is supported by more than 100 patient groups, cancer institutes, hospitals and medical schools including the University of Kansas Cancer Center. More than 12 million Americans have survived cancer thanks in part to the United States' commitment to cancer research and due to advances in cancer prevention, detection, diagnosis and treatment.
"With passage of this resolution, the Senate reaffirms its commitment to advancing important cancer research that saves lives," Sen. Moran said. "Since the National Cancer Act was signed into law 40 years ago this month, the 5-year survival rate for all cancers combined has risen consistently. Today, the National Cancer Institute and its parent agency, the National Institutes of Health, support critical research across the country, enhancing the work of universities, medical schools, teaching hospitals, private bioscience businesses and research institutions in every state. This national commitment to research has saved millions of lives and billions of dollars. But much work remains -- more than 1.5 million Americans are expected to be diagnosed with cancer this year."
Given the vast amount of progress made over the last century and the great potential current research holds, Sen. Moran believes the United States must not waiver on its commitment to advancing disease cures and treatments. In September, he offered an amendment in the Senate Appropriations Committee markup to restore funding to the National Institutes of Health (NIH) budget. This amendment was fully offset and would have prioritized medical research without adding a dime to our nation's annual deficit.